An automated biotin-streptavidin procedure for progesterone evaluation

Area of Science:

• Clinical Chemistry
• Immunoassay Technology
• Endocrinology

Background:

• Progesterone measurement is crucial for various clinical applications, including reproductive health and pregnancy monitoring.
• Traditional methods like radioimmunoassay (RIA) have limitations, necessitating the development of alternative, automated assays.
• The biotin-streptavidin system offers high sensitivity and specificity for immunoassays.

Purpose of the Study:

• To describe and validate an automated biotin-streptavidin procedure for serum progesterone measurement.
• To assess the performance characteristics of the new assay, including linearity, stability, and detection limits.
• To compare the results of the biotin-streptavidin assay with a conventional RIA method.

Main Methods:

• Development of an automated biotin-streptavidin immunoassay for progesterone.
• Evaluation of assay linearity up to 98.3 nmol/L and calibration curve stability for 14 days.
• Assessment of interference from common substances (hemoglobin, bilirubin, monoclonal proteins) and sample types (serum, plasma).

Main Results:

• The assay demonstrated linearity up to 98.3 nmol/L with a stable calibration curve for at least 14 days.
• The lower limit of detection for progesterone was 0.70 nmol/L.
• High correlation (r = 0.991) was observed between the biotin-streptavidin assay and the DPC RIA assay, with acceptable imprecision (CVs 4.6-7.3%).

Conclusions:

• The automated biotin-streptavidin procedure provides accurate and reliable progesterone measurements.
• The method is suitable for serum and various plasma types, with minimal interference from common substances.
• This assay is a robust alternative to RIA for clinical progesterone analysis.